Organisation mondiale de la santé (OMS) · Journal articles

Epidemiological impact of a nationwide measles immunization campaign in Viet Nam: a critical review

Organisation mondiale de la santé
Voir le document original

Le texte intégral est hébergé par l’organisation qui le publie. lawenc.com indexe les métadonnées et renvoie vers la source officielle.

Texte intégral

948 Bulletin of the World Health Organization | December 2008, 86 (12) Epidemiological impact of a nationwide measles immunization campaign in Viet Nam: a critical review Hitoshi Murakami,a Nguyen Van Cuong,b Hong Van Tuan,b Katsuyuki Tsukamoto c & Do Si Hien b Objective To study the impact on measles case incidence of a nationwide measles immunization campaign in Viet Nam, while considering differences in disease surveillance before and after the campaign. Methods A nationwide mass immunization campaign was conducted in the north and south of Viet Nam in 2002 and 2003, respectively. During the campaign, a second vaccination dose was given to children aged 9 months to 9 years, and the reported coverage reached 99% in both zones. National measles case-based surveillance data collected during 2001–2006 were reviewed and analysed. Surveillance performance was assessed in terms of case investigation and specimen collection rates and reporting sensitivity for febrile rash cases. Fisher’s exact test was used to test for differences in indicator values before and after the campaign at the national and regional levels; the Wilcoxon signed-rank test was used at the provincial level. Findings Despite significant improvements in disease surveillance, a dramatic reduction in observed measles incidence was noted nationwide after the immunization campaign, with a drop in the national incidence of confirmed measles cases per 100 000 population from 5.44 in 2001 to 0.14 after the campaign (i.e. 2003 in the north and 2004 in the south; P < 0.001). Rapid measles resurgence was observed in 2005 and 2006 only in the north-western mountainous region of the country. The north did not show a statistically significant age shift for new cases (median age: 9 years in 2001 versus 8 years in 2003; P = 0.113), whereas the south did (median age: 7 years versus 12 years; P < 0.001). Conclusion A campaign approach for controlling measles in developing parts of Asia can prove effective. The swift re-emergence of disease in the north-western region was probably due to suboptimal coverage by the campaign and by the subsequent routine expanded programme on immunization in the north-western mountainous region. Bulletin of the World Health Organization 2008;86:948–955. Une traduction en français de ce résumé figure à la fin de l’article. Al final del artículo se facilita una traducción al español. .ةلاقلما هذهل لماكلا صنلا ةياهن في ةصلاخلا هذهل ةيبرعلا ةمجترلا a Bureau of International Cooperation, International Medical Center of Japan, Ministry of Health, Labour and Welfare, 1-21-1 Toyama, Shinjuku, Tokyo 162-8655, Japan. b National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam. c World Health Organization, Hanoi, Viet Nam. Correspondence to Hitoshi Murakami (e-mail: murakami@it.imcj.go.jp). doi:10.2471/BLT.07.048579 (Submitted: 11 October 2007 – Revised version received: 6 March 2008 – Accepted: 14 April 2008 – Published online: 17 September 2008 ) Introduction Measles is a childhood viral disease associated with a relatively high case- fatality rate, especially in malnourished populations in developing countries.1 It also causes numerous complications.2–4 The disease has been successfully con- trolled in the Americas, where the number of cases decreased dramatically from 2584 in 2002 to 105 in 2003. The incidence has been low ever since.5 The turning point was the introduction of nationwide mass measles immuniza- tion campaigns, usually called catch-up or knockout campaigns, and periodic follow-up campaigns. This supplemen- tary strategy enabled the maintenance of high coverage by childhood measles immunization and the establishment of case-based surveillance involving a serological laboratory network.6 Following success in the Americas, the drive for measles control in other parts of the world was accelerated.7 In 2003, the World Health Assembly re- solved to halve global measles mortality during 1999–2005 by fully implement- ing the joint strategic plan set forth by WHO and the United Nations Children’s Fund. The strategy includes strengthening routine immunization, mass immunization campaigns, case- based surveillance with laboratory con- firmation and optimal care of infected children, including the administration of vitamin A.8 The goal set for 2005 was successfully achieved, with a 60% reduc- tion in global mortality.9 In 2005, the WHO Regional Office for the Western Pacific set a regional goal for the elimi- nation of measles, which was defined as terminating the circulation of domestic strains in the region, by 2012.10 Viet Nam adopted this regional goal and is aiming to achieve it by 2010. Despite a measles immunization coverage rate that has surpassed 93% since 1993 with a one-dose schedule, measles outbreaks have occurred every 7–8 years. This clearly illustrates the limitation of the single-dose approach in interrupting domestic circulation of the measles virus.11 A nationwide mass measles immunization campaign was conducted mainly to provide a second dose of vaccine to children aged 9 months to 9 years. It was carried out in two phases: the north of the country was covered between March and April 2002 and the south between March and April 2003. The campaign in- volved massive social mobilization and included the participation of entities such as the defence ministry, the Red Cross, local government at all levels Research Measles immunization campaign in Viet Nam 949Bulletin of the World Health Organization | December 2008, 86 (12) Hitoshi Murakami et al. reporting outbreaks of diseases associ- ated with febrile rash; venous blood specimens were collected from a few early cases in order to confirm whether an outbreak was really due to measles. Since 2001, and especially after the immunization campaign, the system rapidly developed into a case-based sys- tem in which all suspected measles cases were reported and investigated and specimens were collected. A suspected measles case was defined in one of two ways: (a) any person with fever and a maculopapular (i.e. non-vesicular) rash accompanied by cough, coryza or con- junctivitis; (b) any person suspected by a clinician of having measles. Blood specimens were usually cen- trifuged at a district hospital, and serum was sent to one of two national measles laboratories (the National Institute of Hygiene and Epidemiology in Hanoi or the Ho Chi Minh City Pasteur In- stitute in Ho Chi Minh City). Cases of measles were confirmed in one of three ways: a laboratory-confirmed case was one in which the patient tested positive for measles-specific immunoglobulin- M (IgM) antibodies on the Enzygnost Anti-Measles Virus IgM enzyme im- munoassay (Dade Behring, Marburg, Germany); an epidemiologically con- firmed case was one in which there was documented evidence of exposure to a confirmed measles case within the incubation period; and a clinically confirmed case was one that met the clinical case definition despite the absence of a blood test and a history of exposure. Suspected cases in which labo- ratory test results were negative were discarded as non-measles. The WHO recommends testing all such cases for rubella in countries and areas in which Fig. 1. Incidence of confirmed measles cases in Viet Nam by province, before (2001) and (2003 in the north, 2004 in the south) after the mass measles immunization campaigna < 0.1 0.1–0.9 1–9.9 10 < Confirmed measles cases per 100 000 b Before After a The nationwide mass immunization campaign was conducted in the north of Viet Nam in 2002 and in the south in 2003. 2001 data were analysed for before the campaign. b The horizontal line on the right-hand map indicates the division of the country into the north and south zones. and the prime minister. Also, 169 906 health-care workers at all levels and 412 474 volunteers took part in this historic public health project. As a result, the reported coverage reached 6 684 980 out of 6 729 171 individu- als (99.3%) in the north and 8 389 067 out of 8 466 868 (99.1%) in the south. This paper critically examines the epi- demiological impact of this nationwide measles immunization campaign, while taking into account any changes in surveillance performance from before to after the campaign. Methodology In Viet Nam, measles has been des- ignated a notifiable infectious disease since the 1970s. In 2001, a WHO- recommended measles case-based surveillance system was introduced. Initially it focused on investigating and 950 Bulletin of the World Health Organization | December 2008, 86 (12) Research Measles immunization campaign in Viet Nam Hitoshi Murakami et al. Table 1. Comparison of performance indicators for measles case-based surveillance in Viet Nam before and after the mass measles immunization campaign Performance indicator by zone Before the campaigna After the campaignb P-value from provincal analysisc P-value from regional and nationwide analysesd Case investigation ratee (%) North 686 of 9 365 (7) 196 of 228 (86) 0.002 < 0.001 South 1418 of 4 736 (30) 435 of 696 (63) 0.036 < 0.001 Nationwide 2104 of 14 101 (15) 631 of 924 (68) < 0.001 < 0.001 Specimen collection ratef (%) North 317 of 9 365 (3) 157 of 228 (69) < 0.001 < 0.001 South 746 of 4 736 (16) 392 of 696 (56) < 0.001 < 0.001 Nationwide 1063 of 14 101 (8) 549 of 924 (59) < 0.001 < 0.001 Febrile rash cases reported but discarded as non-measles per 100 000 populationg North 0.20 0.41 0.112 NA South 0.19 1.01 < 0.001 NA Nationwide 0.20 0.74 < 0.001 NA Proportion of silent provincesh (%) North 1 of 28 (4) 9 of 28 (32) NA 0.005 South 4 of 33 (12) 4 of 33 (12) NA 1.000 Nationwide 5 of 61 (8) 13 of 61 (21) NA 0.041 NA, not applicable. a 2001 in the north of Viet Nam and 2002 in the south of Viet Nam. b 2003 in the north of Viet Nam and 2004 in the south of Viet Nam. c P-value derived using the Wilcoxon signed-rank test for the difference between the median values of the indicators before and after the campaign in each province. d P-value derived using Fisher’s exact test for the difference in indicator values recorded before and after the campaign. e Proportion of cases investigated among the total number of suspected measles cases reported. f Proportion of cases for which a serum specimen was collected among the total number of suspected measles cases reported. g The figures do not include suspected cases that were reported but not classified because there was no case investigation. h Proportion of provinces that did not report even one suspected measles case. measles has almost been eliminated. The recommendation was slightly modified and followed in Viet Nam, as has been done in the Caribbean, and all suspected measles cases were tested for rubella-specific IgM.12 We analysed the 2001–2006 na- tional measles surveillance data for Viet Nam. In assessing the campaign’s epidemiological impact, only measles cases confirmed by laboratory results, epidemiological linkage or clinical com- patibility were included. A descriptive epidemiological analysis of confirmed cases was carried out to reveal monthly incidence trends and geographical and age distributions. Pre-campaign cases in the north were defined as those that occurred during 2001, whereas post- campaign cases were those that occurred during 2003. Similarly, 2002 and 2004 were considered the pre- and post- campaign periods in the south. We thus excluded cases that occurred during the campaign phases to avoid possible misclassification and to reflect the same seasons and durations of pre- and post- campaign periods in both north and south. In so doing, we circumvented distortions that could have been intro- duced into the analysis by underlying seasonal fluctuations in measles inci- dence. For the geographical distribution of confirmed measles cases (Fig. 1), the pre-campaign period was defined as 2001 for both north and south to illus- trate the actual geographical variation in the annual incidence across the nation in a single pre-campaign year. Surveillance performance indica- tors, namely the case investigation rate, the specimen collection rate, the pro- portion of silent provinces that reported no febrile rash cases in a year, and the number of reported cases discarded as non-measles per 100 000 population, were derived for before and after the campaign and compared. For each province, the Wilcoxon signed-rank test was used to test for differences between the medians of the indicators before and after the campaign; for the national and regional levels, Fisher’s exact test was used (Table 1). Pre- and post-campaign periods in the north and south were defined in the same way as in the epidemiological analysis. In analysing the change in re- porting sensitivity from before to after the campaign, only reported suspected measles cases that were eventually dis- carded as non-measles were included. This was done to eliminate the effect of the reduction in measles incidence due to the campaign and to ensure that pre- and post-campaign performances were comparable. Even though measles was controlled after the campaign, it is unlikely that the incidence of similar diseases such as rubella would have been affected. The estimated mid-year population was used to calculate measles incidence and the number of cases discarded as non-measles that were re- ported per 100 000 population during each year. The surveillance data set was originally maintained using Microsoft Access software (Microsoft Corp., Red- mond WA, United States of America (USA)) and was analysed using SPSS 10.0J (SPSS Inc., Chicago IL, USA). Research Measles immunization campaign in Viet Nam 951Bulletin of the World Health Organization | December 2008, 86 (12) Hitoshi Murakami et al. Results Impact on monthly incidence Fig. 2 and Fig. 3 depict the number of confirmed measles cases reported each month from 2001 to 2003 in the north and south of Viet Nam through the measles-case-based surveillance system before and after the immuniza- tion campaign. The seasonal peak in incidence occurred from January to May. The campaign targeted this pe- riod of high disease transmission and effectively reduced case incidence. In 2002 in the north, disease incidence was significantly reduced during and after the campaign, while in the south, the usual seasonal surge was noted but was reduced in 2003, and incidence re- mained low after the campaign. Nation- ally, confirmed measles cases dropped steadily and dramatically from 2001 to 2004: 3708, 1806, 855 and 95, re- spectively. Of the 95 confirmed measles cases observed in 2004, five were con- firmed upon laboratory testing of 900 specimens, and 90 were confirmed on clinical grounds. Clearly, measles was very effectively suppressed in 2004. Impact on geographical and age distributions Nationally, the incidence of confirmed measles cases per 100 000 population decreased from 5.44 in 2001 to 0.14 after the campaign (P < 0.001). Fig. 1 shows the population-based incidence Fig. 2. Change in the number of confirmed measles cases reporteda in the north of Viet Nam before and after the mass measles immunization campaignb Nu m be r o f c as es 0 300 Jan 2001 200 100 Apr 2001 Jul 2001 Oct 2001 Jan 2002 Apr 2002 Jul 2002 Oct 2002 Jan 2003 Apr 2003 Jul 2003 Oct 2003 Measles immunization campaign a Cases reported through the measles case-based surveillance system. b The arrow indicates the starting date for the immunization campaign. Fig. 3. Change in the number of confirmed measles cases reporteda in the south of Viet Nam before and after the mass measles immunization campaignb Nu m be r o f c as es 0 700 Jan 2002 Apr 2002 Jul 2002 Oct 2002 600 500 400 300 200 100 Jan 2003 Apr 2003 Jul 2003 Oct 2003 Measles immunization campaign a Cases reported through the measles case-based surveillance system. b The arrow indicates the starting date for the immunization campaign. of confirmed measles cases in each of the 61 provinces in Viet Nam both before the campaign (2001) and after (i.e. 2003 in the north and 2004 in the south). In 2001, the incidence was greater than 10 per 100 000 in 12 prov- inces. After the campaign, most had an incidence of less than 1 per 100 000, proof that effective suppression of mea- sles had been attained in each province. However, the mountainous north-west and the central highlands continued to have a higher incidence than other parts of the country after the campaign. Fig. 4 and Fig. 5 show that measles in children aged under 10 years of age was more successfully reduced in the south than the north. After the cam- paign, the median age for the entire country shifted from 8 to 11 years (P < 0.001 by Mann–Whitney test). On analysing the north and south separately, the former did not show a statistically significant age shift (median age: 9 years in 2001 versus 8 years in 2003; P = 0.113), whereas the latter did (median age: 7 years versus 12 years; P < 0.001). There was also an incidence peak in children aged under 1 year both before and after the campaign, probably due to the neutralizing effect of transferred maternal antibodies on vaccine-induced seroconversion. Change in surveillance performance Both the case investigation rate and the specimen collection rate were significantly better, at the 95% confi- dence level, after the campaign at the provincial, regional and national levels (Table 1). The reporting sensitivity of non-measles febrile rash cases also increased 3.5-fold after the campaign. Using the figures for each province, the change in reporting sensitivity was statistically significant both nationally and in the south (P < 0.001 for both using the Wilcoxon signed-rank test). Of concern was the increased number of “silent” provinces seen in the north after the campaign. Eight of the 28 northern provinces became silent and, consequently, the proportion of silent provinces increased significantly (P = 0.041 using the c² test). Thus, the reporting sensitivity varied between provinces against a background of na- tionwide improvement. In summary, although the proportion of silent prov- inces increased, in general the capacity of case-based surveillance to detect and confirm measles cases was significantly better after the campaign. Long-term impact Despite the success of the immuni- zation campaign, local measles out- breaks were detected as early as 2005 952 Bulletin of the World Health Organization | December 2008, 86 (12) Research Measles immunization campaign in Viet Nam Hitoshi Murakami et al. in Lai Chau province and in Lao Cai province, both in the north-western mountainous region. In total, 293 cases were reported in Lai Chau province, of which 136 were laboratory confirmed and 157 were epidemiologically con- firmed. Of these 293 cases, 150 (51%) were in individuals aged over 15 years. In Lao Cai province, 91 cases were report- ed; 15 were laboratory confirmed and 76 were epidemiologically confirmed. Of these 91 cases, 42 (46%) were in individuals aged over 15 years. In 2006, there was a larger re- surgence of measles involving 1978 confirmed cases, of which 1607 were either laboratory or epidemiologically confirmed. Of these, 1883 cases oc- curred in Dien Bien province, which was part of the former Lai Chau province in the north-western corner of the country bordering China until 2004, when the latter province was divided into two smaller provinces: Dien Bien and Lai Chau. Of the cases that occurred in Dien Ben, 153 were laboratory confirmed and 1355 were epidemiologically confirmed. Only 248 (14%) of these confirmed cases were in individuals aged over 15 years, while 1289 (71%) were in children aged under 10 years. In the same year, a second routine immunization, given at school entry, was introduced into the province. Throughout 2005 and 2006, the main focus of the resurgence was in the territory comprised by the former Lai Chau province. As can be seen in Fig. 1, the incidence in this area did not decrease much after the campaign, which suggests that the campaign was compromised locally. There was no death due to measles in either the 2005 or 2006 outbreak. Fig. 6 shows the annual number of measles cases between 1986 and 2006. Two measles surveillance systems co-existed during 2001–2002: notifi- able diseases surveillance and measles case-based surveillance. The former system confirmed more cases based on physicians’ diagnosis than the latter, which primarily confirmed cases either by laboratory tests or epidemiologically. Consequently, the former system may be considered less specific than the lat- ter because of possible overdiagnosis by physicians. The peak incidence in 2006 was low. In 2007, there were only 17 confirmed measles cases. Cases mainly occurred in the north-western moun- tainous provinces and did not lead to a long-term increase in incidence. Discussion Findings and limitations The incidence of measles in Viet Nam was significantly reduced after the 2002–2003 nationwide immuniza- tion campaign, particularly in 2004. Comparison of the performance of the surveillance system before and after the campaign clearly indicates that the system’s ability to detect and confirm measles cases improved. The reduced measles incidence observed is, therefore, genuine. However, without the swift introduction of a follow-up second im- Fig. 4. Age distribution of measles cases before and after the mass measles immunization campaign in the north of Viet Nam Nu m be r o f c as es 0 200 0 Age (years) 180 160 140 120 100 80 60 40 20 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21+ Before After munization, the reduction in incidence was followed by the rapid resurgence of measles, even though routine second- dose immunization at school entry commenced after 2006. A notable limitation of the study is the underrepresentation of measles cases that were not investigated and laboratory tested before the campaign. It is difficult to determine whether the numerous uninvestigated and untested cases were measles or not. These cases were clinically diagnosed by physicians and reported through the notifiable infectious disease surveillance system rather than the measles case-based sur- veillance system. Although the report- ing sensitivity of non-measles febrile rash cases increased at the national, regional and provincial levels after the campaign, the analysis did not include those uninvestigated and untested cases, and this may have compromised the validity of both the sensitivity estimate and the epidemiological analysis for the pre-campaign period, especially in the north. A global context Between 2000 and 2003, 23 of the 45 countries with the highest measles mortality, including Viet Nam, imple- mented nationwide measles immuniza- tion campaigns. This undoubtedly con- tributed to the dramatic fall in measles mortality worldwide by 2005.9,13 The campaigns in three west African nations (Burkina Faso, Mali and Togo) have been documented14 and the annual number of cases after the campaigns ranged from 333 in Togo to 1712 in Burkina Faso. A reduction in incidence also occurred after the 2002 campaign in Afghanistan15 but was smaller than reductions obtained in the Americas and Viet Nam. Fig. 5. Age distribution of measles cases before and after the mass measles immunization campaign in the south of Viet Nam Nu m be r o f c as es 0 200 0 Age (years) 180 160 140 120 100 80 60 40 20 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21+ Before After Research Measles immunization campaign in Viet Nam 953Bulletin of the World Health Organization | December 2008, 86 (12) Hitoshi Murakami et al. Nu m be r o f c as es 0 70 000 19 86 Year Notifiable diseases surveillance system Measles case-based surveillance system 19 87 19 88 60 000 50 000 40 000 30 000 20 000 10 000 19 89 19 90 19 91 19 92 19 93 19 94 19 95 19 96 19 97 19 98 19 99 20 00 20 01 20 02 20 03 20 04 20 05 20 06 Fig. 6. Annual number of measles cases reported in Viet Nam between 1986 and 2006a a In 2001, only the north of Viet Nam had implemented the measles case-based surveillance system. The reduced incidence of measles following a campaign offers an oppor- tunity to introduce a case-based surveil- lance system involving case investiga- tion and specimen testing. The WHO Regional Office for the Western Pacific16 and the global consensus meeting on monitoring measles elimination 17 both have as a criterion for elimination that the surveillance system should be sensitive enough to report at least one suspected measles case per 100 000 population per year in at least 80% of all districts. In Viet Nam, the reporting sensitivity was 0.74 per 100 000 after the campaign (Table 1), just below the level required to certify elimination. Discussions with preventive medi- cine staff indicate that the increase in silent provinces in the north after the campaign was probably caused by bias and complacency. Bias was due to preventive medicine staff not reporting suspected measles cases because of a fear it would be interpreted as a failure of the immunization campaign and thus damage their reputation. Complacency was due to the belief that there would not be many febrile rash cases after the campaign because of the reduced measles incidence. In the Region of the Americas, estimated reporting rates of suspect- ed measles cases between 2003 and 2006 ranged from 3.55 to 4.34 per 100 000.18–21 During the same period, confirmed measles cases in the region ranged from 75 to 187 per year (in- cidence rate per 100 000 population from 0.01 to 0.02), indicating near elimination. Compared to the America’s sensitive system, Viet Nam’s measles surveillance system was still suboptimal at the time of the study. However, the reporting rate reached 5.19 per 100 000 in 2006, by far the highest among West- ern Pacific countries. In the Western Pacific, the Republic of Korea was the first country to declare measles elimination in 2006, with only 25 new cases (an incidence of 0.52 per 1 million population).22 However, the reporting rate of non-measles febrile- rash cases in the country was 0.18 per 100 000 population, indicating still suboptimal reporting sensitivity.23 Some Pacific island countries have demon- strated limited measles virus transmis- sion since national campaigns in 1997 and 1998, although sporadic outbreaks have been reported,11 and the reporting rate of non-measles febrile-rash cases was 0.20 per 100 000 population.23 In the Hong Kong Special Administra- tive Region of China, the incidence of measles was reduced to 0.9 per 100 000 population in 1998.24 In 2006, it was 1.49 per 100 000 population.23 Challenges faced after the campaign A possible explanation of the rapid resurgence of measles in north-western Viet Nam during 2005–2006 is that older children remained vulnerable because the age group targeted for vac- cination was narrower (i.e. 9 months to 9 years) than recommended (i.e. up to 14 years).25 The change in age distribu- tion after the campaign observed in the south (Fig. 5) and in outbreaks in Lai Chau province and Lao Cai province in 2005 suggest that the virus may continue to circulate among teenagers. Conversely, children aged under 10 years were mainly affected in the larger 2006 outbreak focused on Dien Bien province, which instead indicates sub- optimal immunization coverage. Also, 474 of the 1508 confirmed cases (31%) in the Dien Bien outbreak occurred in children aged under 1 year, pointing to suboptimal coverage by the expanded programme on immunization since 2003. Accordingly, the resurgence was probably due to suboptimal coverage of both the immunization campaign and, thereafter, the expanded programme on immunization. This implies that increasing the upper age limit from 10 to 15 years would not necessarily be effective and would certainly not be cost-effective. An important strategic question is how to maintain the population immu- nity attained in 2004 given the varia- tion in immunity across the country. Viet Nam has the advantage that cover- age of the routine first dose of measles vaccination is generally high: 98% and 94% in the north and the south, respectively, before the campaign, and 97% and 96%, respectively, after. This background no doubt contributed to the very effective suppression of mea- sles after the campaign. In 2006, the country introduced the second routine immunization dose at school entry in 43 out of 64 provinces, with a coverage exceeding 98%. The county is reluctant to imple- ment nationwide follow-up campaigns mainly because of concern about the cost. In the nationwide catch-up cam- paign described here, US$ 2.0 mil- lion was spent on operational costs in addition to the cost of the necessary vaccines, syringes and safety boxes pro- vided by Japan. This expenditure was unprecedented for a mass public health intervention in the country. A follow- up campaign targeting 1- to 4-year- olds will require nearly half the money 954 Bulletin of the World Health Organization | December 2008, 86 (12) Research Measles immunization campaign in Viet Nam Hitoshi Murakami et al. spent on the catch-up campaign. In November and December 2007, an im- munization campaign was carried out in 17 mountainous provinces in the north targeting 6- to 20-year olds (1- to 20-year-olds in four provinces with the highest risk) in response to the 2005 and 2006 outbreaks. Viet Nam is aiming to achieve the level of immunity required to eliminate measles by maintaining a high coverage of routine first vaccinations in infants, rou- tine second vaccinations at school entry and supplementary local campaigns in high-risk districts. The effectiveness of this strategy should be closely monitored since the country is a rare example of a tropical developing country outside the Americas that is pursuing measles elimination fol- lowing a catch-up campaign, which this critical epidemiological review found to be very effective. ■ Acknowledgements The authors thank the regional, provin- cial, district and subdistrict preventive medicine staff in Viet Nam for estab- lishing and implementing the measles case-based surveillance programme during the study period. Funding: This review was carried out while some of the authors were as- signed to the WHO Viet Nam Office. Therefore, part of the data collection and analysis was indirectly funded from that Office’s budget. Competing interests: None declared. Résumé Impact épidémiologique d’une campagne nationale de vaccination antirougeoleuse au Viet Nam : revue critique Objectif Etudier l’impact d’une campagne nationale de vaccination antirougeoleuse de masse au Viet Nam sur l’incidence des cas de rougeole, en considérant les variations des résultats de la surveillance de cette maladie avant et après la campagne. Méthodes Une campagne nationale de vaccination de masse a été menée dans le Nord, puis dans le Sud du pays, en 2002 et 2003 respectivement. Dans le cadre de cette campagne, une deuxième dose de vaccin a été administrée aux enfants de 9 mois à 9 ans et le taux de couverture rapporté a atteint 99 % dans les deux zones. Les données de surveillance nationale de la rougeole à partir des cas recensés, recueillies sur la période 2001-2006, ont été examinées et analysées. Les résultats de la surveillance ont été évalués en termes de taux d’investigation des cas et de collecte d’échantillon, et d’après la sensibilité de la notification pour les cas d’éruption fébrile. On a utilisé le test exact de Fisher pour rechercher des différences entre les valeurs indicatrices avant et après la campagne, au niveau du pays et des régions et on a fait appel au test de Wilcoxon (test des rangs signés) au niveau provincial. Résultats Malgré de grandes améliorations dans la surveillance de la maladie, on a observé une forte chute de l’incidence de la rougeole à l’issue de la campagne de vaccination, avec une baisse de l’incidence nationale des cas confirmés pour 100 000 habitants de 5,44 en 2001 à 0,14 après la campagne (c’est-à-dire en 2003 dans le Nord et en 2004 dans le Sud, p < 0,001). Une résurgence rapide de la rougeole a été observée en 2005 et 2006, mais seulement dans la région montagneuse du Nord-Ouest. On n’a pas observé dans le Nord de décalage statistiquement significatif de l’âge médian des nouveaux cas (âge médian : 9 ans en 2001 contre 8 ans en 2003, p = 0,113), en revanche ce fut le cas dans le Sud (âge médian passant de 7 ans en 2001 à 12 ans en 2003, p < 0,001). Conclusion Une démarche de type campagne vaccinale peut s’avérer efficace pour endiguer la rougeole dans les régions en développement d’Asie. La réémergence de cette maladie dans la région du Nord-Ouest était probablement due à une couverture sous-optimale de cette région par la campagne et par le programme étendu de vaccination systématique ultérieurement mis en place. Resumen Impacto epidemiológico de una campaña nacional de inmunización antisarampionosa en Viet Nam: reseña crítica Objetivo Estudiar el impacto en la incidencia de casos de sarampión de una campaña nacional de inmunización antisarampionosa en Viet Nam, teniendo en cuenta la diferente eficacia de la vigilancia de la enfermedad antes y después de la campaña. Métodos Se llevó a cabo una campaña nacional de inmunización masiva en el norte y el sur de Viet Nam en 2002 y en 2003, respectivamente. Durante la campaña, se administró una segunda dosis a los niños de 9 meses a 9 años de edad, con una cobertura notificada que alcanzó el 99% en las dos zonas. Se analizaron los datos nacionales de vigilancia de los casos de sarampión reunidos durante el periodo 2001–2006. La eficacia de la vigilancia se determinó en función de las tasas de investigación de casos y de recogida de muestras, así como de la sensibilidad de la notificación de los casos de exantema febril. Se empleó la prueba exacta de Fisher para analizar las diferencias entre los indicadores antes y después de la campaña a nivel nacional y regional; con los datos de nivel provincial se aplicó la prueba de rangos con signo de Wilcoxon. Resultados Pese a mejorar considerablemente la vigilancia de la enfermedad, tras la campaña de inmunización se registró una muy marcada reducción de la incidencia observada de sarampión a nivel nacional, con una caída de la incidencia nacional de casos confirmados por 100 000 habitantes de 5,44 en 2001 a 0,14 después de la campaña (esto es, en 2003 en el norte y en 2004 en el sur; p < 0,001). El rápido resurgimiento de casos de sarampión observado en 2005 y 2006 se limitó a la región montañosa noroccidental del país. En el norte no se observó un desplazamiento estadísticamente significativo de la edad en los nuevos casos (mediana de la edad: 9 años en 2001, frente a 8 años en 2003; p = 0,113), mientras que en el sur sí se dio tal desplazamiento (mediana: 7 años, frente a 12 años; p < 0,001). Conclusión La realización de campañas puede ser un arma eficaz para controlar el sarampión en las zonas en desarrollo de Asia. La súbita reaparición de la enfermedad en la región montañosa noroccidental se debió probablemente a una cobertura subóptima tanto de la campaña como del posterior programa ampliado de inmunización sistemática en dicha región. Research Measles immunization campaign in Viet Nam 955Bulletin of the World Health Organization | December 2008, 86 (12) Hitoshi Murakami et al. References Halsey NA. Measles in developing countries. 1. BMJ 2006;333:1234. PMID:17170396 doi:10.1136/bmj.39058.361620.BE Fetuga2. MB, Jokanma OF, Ogunfowora OB, Abiodun R. A ten-year study of measles admissions in a Nigerian teaching hospital. Niger J Clin Pract 2007;10:41-6. PMID:17668714 Filia3. A, Brenna A, Pana A, Moggio Cavallaro G, Massari M, Ciofi Degli Atti ML. Health burden and economic impact of measles-related hospitalizations in Italy in 2002-2003. BMC Public Health 2007;7:169. PMID:17650298 doi:10.1186/1471-2458-7-169 Bellini4. WJ, Rota JS, Lowe LE, Katz RS, Dyken PR, Zaki SR, et al. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 2005;192:1686-93. PMID:16235165 doi:10.1086/497169 Centers5. for Disease Control and Prevention (CDC). Progress toward measles elimination — region of the Americas, 2002-2003. MMWR Morb Mortal Wkly Rep 2004;53:304-6. PMID:15085074 De6. Quadros CA, Olive JM, Hersh BS, Strassburg MA, Henderson DA, Brandling-Bennett D, et al. Measles elimination in the Americas. Evolving strategies. JAMA 1996;275:224-9. PMID:8604176 doi:10.1001/ jama.275.3.224 Hoekstra7. EJ, McFarland JW, Shaw C, Salama P. Reducing measles mortality, reducing child mortality. Lancet 2006;368:1050-2. PMID:16997650 doi:10.1016/S0140-6736(06)69335-5 Measles8. mortality reduction and regional elimination: strategic plan 2001-2005. Geneva: WHO & United Nations Children’s Fund (UNICEF); 2001. pp. 6-15. Wolfson9. LJ, Strebel PM, Gacic-Dobo M, Hoekstra EJ, McFarland JW, Hersh BS. Has the 2005 measles mortality reduction goal been achieved? A natural history modeling study. Lancet 2007;369:191-200. PMID:17240285 doi:10.1016/S0140-6736(07)60107-X The10. World Health Organization Regional Committee for the Western Pacific. Resolution no. WPR/RC54.R3 (Expanded Programme on Immunization: measles and hepatitis B). Manila: WHO Regional Office for the Western Pacific; 2003. McFarland11. JW, Mansoor OD, Yang B. Accelerated measles control in the Western Pacific region. J Infect Dis 2003;187 Suppl 1;s246-51. PMID:12721921 doi:10.1086/368039 Irons12. B, Carrasco P, Morris-Glasgow V, Castillo-Solórzano C, de Quadros CA. Integrating measles and rubella surveillance: the experience in the Caribbean. J Infect Dis 2003;187 Suppl 1;s153-7. PMID:12721907 doi:10.1086/368031 Centers13. for Disease Control and Prevention (CDC). Progress in reducing measles mortality-worldwide, 1999-2003. MMWR Morb Mortal Wkly Rep 2005;54:200-3. PMID:15744229 Centers14. for Disease Control and Prevention (CDC). Measles mortality reduction-West Africa, 1996-2002. MMWR Morb Mortal Wkly Rep 2004; 53:28-30. Centers15. for Disease Control and Prevention (CDC), Nationwide measles vaccination campaign for children aged 6 months-12 years. Afghanistan, 2002. MMWR Morb Mortal Wkly Rep 2003;52:363-6. Field16. guidelines for measles elimination. Manila: WHO Regional Office for the Western Pacific; 2004. p. 5. Monitoring17. the interruption of indigenous measles transmission, Cape Town meeting, 14 October 2003. Wkly Epidemiol Rec 2004;7:70-2. Measles18. Weekly Bulletin. Vol. 9, no. 53. Washington, DC: Pan American Health Organization; 2003. Available from: http://www.paho.org/english/AD/FCH/IM/ MeaslesWeeklyBulletin.htm [accessed on 1 September 2008]. Measles Weekly Bulletin19. . Vol. 10, no. 52. Washington, DC: Pan American Health Organization; 2004. Measles Weekly Bulletin20. . Vol. 11, no. 52. Washington, DC: Pan American Health Organization;2005. Measles Weekly Bulletin21. . Vol. 12, no. 52. Washington, DC: Pan American Health Organization; 2006. Available from: http://www.paho.org/english/AD/ FCH/IM/MeaslesWeeklyBulletin.htm [accessed on 1 September 2008]. Measles Bulletin22. . Vol. 1, issue 11. Manila: WHO Regional Office for the Western Pacific; 2006. Available from: http://www.wpro.who.int/sites/epi/ documents/MeaslesBulletin.htm [accessed on 1 September 2008]. Measles Bulletin23. . Vol. 1, issue 12. Manila: WHO Regional Office for the Western Pacific; 2007. Available from: http://www.wpro.who.int/sites/epi/ documents/MeaslesBulletin.htm [accessed on 1 September 2008]. Chuang SK, Lau YL, Lim WL, Chow CB, Tsang T, Tse LY. Mass measles 24. immunization campaign: experience in the Hong Kong Special Administrative Region of China. Bull World Health Organ 2002;80:585-91. PMID:12163924 Measles eradication field guide 25. [Technical paper no. 41]. Washington, DC: Pan American Health Organization;2003. pp. 23-30. صخلم مان تييف في ةبصحلا دض ميعطتلل دلابلل ةلماش ةلمحل يجولوييمديبلإا رثلأا دض دلابلل ةلماش ميعطت ةلمح يرثأت ةفرعم ةساردلا هذه تفدهتسا :ضرغلا في ذخلأا عم ،دلبلا في ةبصحلا تلااح عوقو لدعم لىع مان تييف في ةبصحلا .اهدعبو ةلمحلا لبق ضرلما د ُّصرت في قورفلا رابتعلاا 2002 ماع في مان تييف لماش في ةلماش ميعطت ةلمح تيرُجأ :ةقيرطلا حيقلت ةعرج ءاطعإ ةلمحلا هذه في متو .2003 ماع في دلابلا بونج فيو لدعم لصوو ،تاونس 9 لىإ روهش 9 رمع في مه نيذلا لافطلأل ةيناث د ُّصرت تانايب ليلحتو ةعجارم تتمو .ينتقطنلما في %99 لىإ غَّلبلما ةيطغتلا مت ماك .2006 - 2001 ةدلما للاخ تعمُج يتلا ةينطولا ةبصحلا تلااح تانيعلا عمج تلادعمو تلااحلا ِّيصقت ثيح نم د ُّصترلا ةيلمع ءادأ مييقت شريفل ةقدلا رابتخا مدخُتساو .يومُحلا حفطلا تلااح نع غيلبتلا ةيساسحو اهدعبو ةلمحلا لبق ِّيشؤملل مَيِقلا في قورفلا رابتخلا Fisher Exact Test نوسكوكلو رابتخا مدخُتسا ماك ؛قطانلما ديعصو ينطولا ديعصلا لىع .تايلاولا ديعص لىع Wilcoxon signed-rank test في يرذج ضافخنا ظحول ،ضرلما د ُّصرت في سومللما ن ُّسحتلا مغرب :جئاتنلا عم ،ميعطتلا ةـلمح دعب يرطقلا قاطنلا لىع ةبصحلل ظحلالما عوقولا لدعم ةد َّكؤلما ةـبصحلا تلااحل ظحلالما ينطولا عوقولا لدعم في ضافخنا ثودح ةلمحلا دعب 0.14 لىإ 2001 ماع في 5.44 نم ،ناكسلا نم 100 000 لكل ةميق دنع ؛)دلابلا بونج في 2004 ماع فيو ،دلابلا لماش في 2003 ماع في يأ( 2005 يماع في ةبصحلل عيسر ثاعبنا ظحول ماك .)0.001 > P لماتحا دلابلا لماش في ظحلاُي لمو .مان تييف بيرغ لماشب ةيلبجلا ةقطنلما في 2006و تاونس 9 :طيسولا رمعلا( ةثيدحلا تلااحلا رمع في ًايئاصحإ هب دتعُي فلاتخا ،)0.113 = P لماتحا ةميق دنع ؛2003 ماع في تاونس 8 لباقم 2001 ماع في 12 لباقم تاونس 7 :طيسولا رمعلا( )دلابلا بونج في فلاتخا ظحول نكلو .)0.001 > P لماتحا ةميق دنع ؛ةنس في ةيمانلا قطانلما في ةبصحلا ةحفاكم في تلامحلا بولسلأ نكيم :جاتنتسلاا بيرغ لماش في ضرملل عيسرلا ثاعبنلاا ىزعُي دقو .هتيلاعف تبثي نأ ايسآ ميعطتلا ةطشنأبو ةلمحلا ةطشنأب لثملأا نود ةيطغتلا لدعم لىإ دلابلا ةيلبجلا ةقطنلما في عينمتلل ع َّسولما جمانبرلا لَبِق نم ةذ َّفنلما ةقحلالا ينيتورلا .دلابلا بيرغ لماشب

Informations clés
Type de document Journal articles
Date d'adoption
Source Organisation mondiale de la santé